Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 562 of 6351
-
Could a breath test reveal Parkinson's risk?
Knowledge-focused Recruiting nowGut problems, such as constipation, can have an important impact on quality of life of people who have them, and have been associated with higher risk of developing neurological diseases such as Parkinson's or Alzheimer's disease. Recent studies suggest that gut problems may als…
Sponsor: University of Cambridge • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New fertility drug aims to boost IVF live birth rates
Disease control Recruiting nowThe goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reprod…
Phase 3 • Sponsor: Granata Bio Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Smart combo attack: new trial matches lung cancer drugs to tumor fingerprints
Disease control Not yet recruitingThis is an open-label umbrella study conducted in first treatment ES-SCLC patients, employing a novel umbrella trial design (biomarker-integrated multi-arm trial with a shared ICI+chemotherapy control arm). Eligible patients were assigned to trial arms based on biomarker expressi…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Weekly injection could tame bleeding in kids with Hard-to-Treat ITP
Disease control Not yet recruitingThe aim is to evaluate safety and efficacy of Romiplostim in the treatment of chronic ITP in children
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New monthly shot could transform opioid addiction care in developing nations
Disease control Not yet recruitingThe goal of the proposed study is to generate evidence on the acceptability, feasibility, effectiveness, and cost-effectiveness of introducing long-acting depot buprenorphine (LADB) as an additional option for the treatment of opioid dependence in low- and middle-income countries…
Sponsor: PATH • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug aims to stop skin lymphoma from returning after transplant
Disease control Not yet recruitingAllogeneic hematopoietic stem cell transplantation (alloHSCT) showed efficacy in advanced-stage, high-risk, treatment sensitive cutaneous T-cell lymphomas (CTCL) in a prospective, propensity score-matched controlled study (CUTALLO) published by our group in the Lancet in 2023. Ne…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC
-
New combo aims to wipe out returning nose cancer with chemo, immunotherapy, and surgery
Disease control Not yet recruitingNasopharyngeal carcinoma (NPC) is an endemic malignancy in Southern China and southeast Asia. Despite intensive radical therapy, between 15% and 30% of NPC patients develop relapse. Recent phase III randomized-controlled trials conducted in China demonstrated an improvement of pr…
Phase 2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 26, 2026 13:57 UTC
-
Could a Late-Stage clot buster help stroke patients without surgery?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if tenectplase works to acute ischemic stroke (AIS) with onset 4.5-9 hours. It will also learn about the safety of tenectplase in AIS with onset 4.5-9 hours. The main question it aims to answer is: Does tenectplase improve the 90-days f…
Phase 3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jun 26, 2026 15:50 UTC
-
Could immune cells from your own body help you carry a baby?
Disease control Not yet recruitingThe aim of this study is to verify the efficacy of in vitro induction of autologous decidual-like NK cells therapy for reproductive failure associated with uterine NK cells abnormalities.
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Supercharged immune cells take on tough lupus cases
Disease control Recruiting nowThis is an investigator-initiated trial aimed at assessing the safety and efficacy of ultra-fast autologous CD19-targeted CAR-T cells in the treatment of refractory systemic lupus erythematosus.
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for hard-to-treat colorectal cancer: triple-drug combo enters human trials
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and tolerability of escalating doses of ABT-301 in combination with fixed doses of tislelizumab 200 mg IV infusion and bevacizumab 7.5 mg/kg IV infusion Q3W, in participants with pMMR/non-MSI-H colorectal cancer (CRC). It …
Phase 1/2 • Sponsor: Anbogen Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New cocktail aims to knock out rectal cancer before surgery
Disease control Recruiting nowThis is a prospective, single-center, single-arm study evaluating the combination regimen of liposomal irinotecan, capecitabine, and enlonstobart combined with short-course radiotherapy as neoadjuvant therapy for locally advanced rectal cancer.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to keep opioid patients on recovery track after ER visit
Disease control Recruiting nowThe main purpose of this stepped wedge trial will be to test the impact of a bundle of implementation strategies designed to improve ED-outpatient care coordination on long-term buprenorphine retention among adult patients who start buprenorphine for opioid use disorder in a hosp…
Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New stroke device aims to quickly clear blocked arteries
Disease control Recruiting nowThe primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)
Sponsor: Penumbra Inc. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New radiation approach aims to improve sarcoma surgery outcomes
Disease control Not yet recruiting"This prospective, single-institution Phase I/II clinical trial investigates the safety, feasibility, and preliminary efficacy of preoperative carbon-ion radiotherapy (CIRT) for patients with resectable soft tissue sarcoma. Given the radioresistant nature of sarcomas and the limi…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a shorter TB course work for those with unclear test results?
Disease control Not yet recruitingPeople living in high TB burden communities who undergo active case finding for TB may have chest X-ray changes suggestive of TB but their sputum test can be negative for the TB bacteria or they are unable to provide a sputum sample. This means they have bacteriologically unconfi…
Phase 3 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
New Dual-Action drug shows promise for kidney cancer patients
Disease control By invitation onlyThis study is testing a new medicine called AK112 (Yivoximab) for people with advanced kidney cancer that has spread to other parts of the body (metastatic clear cell renal cell carcinoma). AK112 is a special kind of drug called a dual-target antibody that works in two ways: it h…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immune cell therapy GT201 targets advanced tumors in early trial
Disease control Recruiting nowThis is a multicenter Phase I/II clinical trial. It aims to evaluate the safety, tolerability, efficacy and pharmacokinetics (PK) of GT201 in patients with advanced solid tumors.
Phase 1/2 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Targeted chemotherapy infusion aims to control advanced stomach cancer
Disease control Recruiting nowGastric cancer is the fifth most common malignancy worldwide in terms of both incidence and mortality. The majority of cases are diagnosed at advanced stage-often presenting with severe complications such as malignant stricture, obstruction, bleeding, and cancer-related malnutrit…
Phase 2 • Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cholera vaccine trial aims to protect south africans of all ages
Vaccine Recruiting nowThis Phase I/III clinical trial is intended to establish the immunogenicity and safety profile of Biovac OCV-S compared to available WHO pre-qualified vaccine Euvichol®-Plus in healthy adults and children and in adult people living with HIV (PLWH). The lot-to-lot consistency of B…
Phase 3 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 08:10 UTC